DNA replication inhibitors (Targanta)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug NameDNA replication inhibitors (Targanta)
Drug Alias NameDNA polymerase inhibitors (Targanta)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVirus DNA polymerase inhibitorsDNA primase inhibitors
TargetsVirus DNA polymeraseDNA primase
Therapy Area/IndicationsGram-Positive Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTarganta Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTarganta Therapeutics
Active IndicationsN/A
Inactive IndicationsGram-Positive Bacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A